1. Academic Validation
  2. Enhanced autophagic clearance of amyloid-β via HDAC6-mediated V-ATPase assembly and lysosomal acidification protects against Alzheimer's disease in vitro and in vivo

Enhanced autophagic clearance of amyloid-β via HDAC6-mediated V-ATPase assembly and lysosomal acidification protects against Alzheimer's disease in vitro and in vivo

  • Neural Regen Res. 2024 Jul 10. doi: 10.4103/NRR.NRR-D-23-01633.
Zhimin Long 1 2 Chuanhua Ge 1 2 Yueyang Zhao 1 2 Yuanjie Liu 1 2 Qinghua Zeng 1 2 Qing Tang 1 3 Zhifang Dong 4 5 6 7 Guiqiong He 1 2
Affiliations

Affiliations

  • 1 Institute of Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • 2 Department of Anatomy, Chongqing Medical University, Chongqing, China.
  • 3 Department of Physiology, Chongqing Medical University, Chongqing, China.
  • 4 Pediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • 5 Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • 6 National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • 7 Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Abstract

Recent studies have suggested that abnormal acidification of lysosomes induces autophagic accumulation of Amyloid-β in neurons, which is a key step in senile plaque formation. Therefore, restoring normal lysosomal function and rebalancing lysosomal acidification in neurons in the brain may be a new treatment strategy for Alzheimer's disease. Microtubule acetylation/deacetylation plays a central role in lysosomal acidification. Here, we show that inhibiting the classic microtubule deacetylase histone deacetylase 6 with an histone deacetylase 6 shRNA or thehistone deacetylase 6 inhibitor valproic acid promoted lysosomal reacidification by modulating V-ATPase assembly in Alzheimer's disease. Furthermore, we found that treatment with valproic acid markedly enhanced Autophagy, promoted clearance of Amyloid-β aggregates, and ameliorated cognitive deficits in a mouse model of Alzheimer's disease. Our findings demonstrate a previously unknown neuroprotective mechanism in Alzheimer's disease, in which histone deacetylase 6 inhibition by valproic acid increases V-ATPase assembly and lysosomal acidification.

Figures
Products